Activation of Liver X Receptor Decreases Atherosclerosis in Ldlr −/− Mice in the Absence of ATP-Binding Cassette Transporters A1 and G1 in Myeloid Cells
- 1 February 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 34 (2) , 279-284
Abstract
Objective—: Liver X receptor (LXR) activators decrease atherosclerosis in mice. LXR activators (1) directly upregulate genes involved in reverse cholesterol transport and (2) exert anti-inflammatory effects mediated by transrepression of nuclear factor-κB target genes. We investigated whether myeloid cell deficiency of ATP-binding cassette transporters A1 and G1 (ABCA1/G1), principal targets of LXR that promote macrophage cholesterol efflux and initiate reverse cholesterol transport, would abolish the beneficial effects of LXR activation on atherosclerosis. Approach and Results—: LXR activator T0901317 substantially reduced inflammatory gene expression in macrophages lacking ABCA1/G1. Ldlr −/− mice were transplanted with Abca1 −/− Abcg1 −/− or wild-type bone marrow (BM) and fed a Western-type diet for 6 weeks with or without T0901317 supplementation. Abca1/g1 BM deficiency increased atherosclerotic lesion complexity and inflammatory cell infiltration into the adventitia and myocardium. T0901317 markedly decreased lesion area, complexity, and inflammatory cell infiltration in the Abca1 −/− Abcg1 −/− BM–transplanted mice. To investigate whether this was because of macrophage Abca1/g1 deficiency, Ldlr −/− mice were transplanted with LysmCreAbca1 fl/fl Abcg1 fl/fl or Abca1 fl/fl Abcg1 fl/fl BM and fed Western-type diet with or without the more specific LXR agonist GW3965 for 12 weeks. GW3965 decreased lesion size in both groups, and the decrease was more prominent in the LysmCreAbca1 fl/fl Abcg1 fl/fl group. Conclusions—: The results suggest that anti-inflammatory effects of LXR activators are of key importance to their antiatherosclerotic effects in vivo independent of cholesterol efflux pathways mediated by macrophage ABCA1/G1. This has implications for the development of LXR activators that lack adverse effects on lipogenic genes while maintaining the ability to transrepress inflammatory genes.Keywords
This publication has 39 references indexed in Scilit:
- Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Macrophages Increases Inflammation and Accelerates Atherosclerosis in MiceCirculation Research, 2013
- HDL and Glut1 inhibition reverse a hypermetabolic state in mouse models of myeloproliferative disordersJournal of Experimental Medicine, 2013
- Feedback Regulation of Cholesterol Uptake by the LXR–IDOL–LDLR AxisArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Intestinal Specific LXR Activation Stimulates Reverse Cholesterol Transport and Protects from AtherosclerosisCell Metabolism, 2010
- ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell ProliferationScience, 2010
- Non-redundant roles for LXR and LXR in atherosclerosis susceptibility in low density lipoprotein receptor knockout miceJournal of Lipid Research, 2010
- The Benzenesulfoamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] Is a Novel Retinoic Acid Receptor-Related Orphan Receptor-α/γ Inverse AgonistMolecular Pharmacology, 2010
- Liver X receptor agonism promotes articular inflammation in murine collagen‐induced arthritisArthritis & Rheumatism, 2009
- Native LDL Upregulation of ATP-Binding Cassette Transporter-1 in Human Vascular Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Role of LXRs in control of lipogenesisGenes & Development, 2000